EP 0427762 A1 19910522 - SUBSTITUTED PHENYLACETONITRILES USED TO OVERCOME RESISTANCE TO DRUGS IN ONCOLYTIC THERAPY.
Title (en)
SUBSTITUTED PHENYLACETONITRILES USED TO OVERCOME RESISTANCE TO DRUGS IN ONCOLYTIC THERAPY.
Title (de)
SUBSTITUIERTE PHENYLACETONITRILE ZUR VERWENDUNG ALS RESISTENZBRECHER IN DER ONKOLYBISCHEN THERAPIE.
Title (fr)
PHENYLACETONITRILES SUBSTITUES UTILISES POUR EMPECHER LA RESISTANCE AUX MEDICAMENTS LORS D'UNE THERAPIE ONCOLYTIQUE.
Publication
Application
Priority
DE 3826796 A 19880806
Abstract (en)
[origin: WO9001318A1] Use of substituted phenylacetonitriles of formula (I) to overcome resistance to anti-malarial agents.
Abstract (fr)
Utilisation de phénylacétonitriles substitués ayant la formule (I) pour empêcher la résistance aux médicaments cancérostatiques.
IPC 1-7
IPC 8 full level
A61K 31/275 (2006.01); A61K 31/277 (2006.01); A61P 3/00 (2006.01); A61P 3/14 (2006.01); A61P 35/00 (2006.01); C07C 255/42 (2006.01); C07C 255/43 (2006.01)
CPC (source: EP)
A61K 31/275 (2013.01); A61P 3/00 (2017.12); A61P 3/14 (2017.12); A61P 35/00 (2017.12); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 9001317A1
Designated contracting state (EPC)
AT BE CH DE FR GB IT LI NL
DOCDB simple family (publication)
WO 9001318 A1 19900222; AP 102 A 19901023; AP 8900134 A0 19891031; AT E113206 T1 19941115; DE 3826796 A1 19900208; DE 58908571 D1 19941201; EP 0427747 A1 19910522; EP 0427747 B1 19941026; EP 0427762 A1 19910522; JP H04500067 A 19920109; WO 9001317 A1 19900222
DOCDB simple family (application)
EP 8900901 W 19890801; AP 8900134 A 19890804; AT 89908428 T 19890801; DE 3826796 A 19880806; DE 58908571 T 19890801; EP 8900900 W 19890801; EP 89908428 A 19890801; EP 89908826 A 19890801; JP 50834189 A 19890801